RiceBran Technologies - RIBT Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for RiceBran Technologies in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" RIBT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RIBT, but not buy additional shares or sell existing shares.
View RIBT analyst ratings or view top-rated stocks.

RiceBran Technologies' stock was trading at $3.49 at the beginning of 2022. Since then, RIBT shares have decreased by 52.4% and is now trading at $1.66.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our RIBT earnings forecast.

RiceBran Technologies (NASDAQ:RIBT) issued its quarterly earnings results on Thursday, August, 11th. The company reported ($0.50) EPS for the quarter. The firm earned $10.19 million during the quarter. RiceBran Technologies had a negative net margin of 32.92% and a negative trailing twelve-month return on equity of 44.61%.

RiceBran Technologies shares reverse split on the morning of Friday, August 26th 2022. The 1-10 reverse split was announced on Friday, August 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other RiceBran Technologies investors own include OPKO Health (OPK), vTv Therapeutics (VTVT), Pareteum (TEUM), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Palatin Technologies (PTN), Trevena (TRVN), VBI Vaccines (VBIV), VistaGen Therapeutics (VTGN) and Alimera Sciences (ALIM).

RiceBran Technologies trades on the NASDAQ under the ticker symbol "RIBT."

RiceBran Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.01%), Arnhold LLC (0.39%), FNY Investment Advisers LLC (0.20%), Jane Street Group LLC (0.13%) and UBS Group AG (0.07%). Insiders that own company stock include Ari David Gendason, Brent David Rosenthal, Brent Robert Rystrom, David I Chemerow, Grain Co Continental and Todd T Mitchell.
View institutional ownership trends.

Shares of RIBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RIBT stock can currently be purchased for approximately $1.66.

RiceBran Technologies (NASDAQ:RIBT) has a market capitalization of $8.68 million and generates $31.13 million in revenue each year. The company earns $-8,950,000.00 in net income (profit) each year or ($2.30) on an earnings per share basis.

The company employs 101 workers across the globe.

RiceBran Technologies' mailing address is 1330 LAKE ROBBINS DRIVE SUITE 250, THE WOODLANDS TX, 77380. The official website for the company is www.ricebrantech.com. The company can be reached via phone at (281) 675-2421, via email at rich@ascendantpartnersllc.com, or via fax at 602-522-3001.